Stay updated on AG-120 Combo vs Placebo with Azacitidine in AML Clinical Trial
Sign up to get notified when there's something new on the AG-120 Combo vs Placebo with Azacitidine in AML Clinical Trial page.

Latest updates to the AG-120 Combo vs Placebo with Azacitidine in AML Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedFooter shows a new revision label 'Revision: v3.3.3' and the 'HHS Vulnerability Disclosure' link has been removed. These are administrative updates and do not modify trial data or core page content.SummaryDifference0.1%

- Check29 days agoNo Change Detected
- Check50 days agoChange DetectedThe page history now shows Revision: v3.3.2 added and Revision: v3.2.0 removed, appearing as administrative versioning information rather than content changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check57 days agoChange DetectedNew sections 'Outcome Measures (Results)' and 'Study Status' were added to present trial results and current status. The update expands access to essential trial information for participants and researchers.SummaryDifference0.5%

- Check71 days agoChange DetectedA new record history entry (Version 79, 2024-09-04) was added, documenting latest updates to the study record.SummaryDifference0.0%

- Check100 days agoChange DetectedThe page now includes an operating-status notice and a version update to v3.2.0, while removing the previous v3.1.0 reference.SummaryDifference8%

- Check107 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.2%

Stay in the know with updates to AG-120 Combo vs Placebo with Azacitidine in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AG-120 Combo vs Placebo with Azacitidine in AML Clinical Trial page.